GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

myxopyronin B   Click here for help

GtoPdb Ligand ID: 14300

PDB Ligand
Compound class: Natural product
Comment: Myxopyronin is a natural product with antibacterial activity, originally isolated from cultures of the soil-dwelling myxobacterium Myxococcus fulvus as a mixture of two components (myxopyronin A and myxopyronin B) [5]. Total synthesis has been reported [4]. We show the structure for myxopyronin B which is reported to be the component with the greater activity [5]. Functionally, it inhibits bacterial RNA polymerase [5].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 13
Topological polar surface area 101.93
Molecular weight 431.52
XLogP 4.86
No. Lipinski's rules broken 1

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCCC/C(=C/C=C(\C)/C(=O)C1=C(C=C([C@H](C)CC/C=C/NC(=O)OC)OC1=O)O)/C
Isomeric SMILES CCCC/C(=C/C=C(\C)/C(=O)C1=C(C=C(OC1=O)[C@H](C)CC/C=C/NC(=O)OC)O)/C
InChI InChI=1S/C24H33NO6/c1-6-7-10-16(2)12-13-18(4)22(27)21-19(26)15-20(31-23(21)28)17(3)11-8-9-14-25-24(29)30-5/h9,12-15,17,26H,6-8,10-11H2,1-5H3,(H,25,29)/b14-9+,16-12+,18-13+/t17-/m1/s1
InChI Key SPQDIDVJAZFBRL-WXFBSNOUSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Belogurov GA, Vassylyeva MN, Sevostyanova A, Appleman JR, Xiang AX, Lira R, Webber SE, Klyuyev S, Nudler E, Artsimovitch I et al.. (2009)
Transcription inactivation through local refolding of the RNA polymerase structure.
Nature, 457 (7227): 332-5. [PMID:18946472]
2. Brauer M, Herrmann J, Zühlke D, Müller R, Riedel K, Sievers S. (2022)
Myxopyronin B inhibits growth of a Fidaxomicin-resistant Clostridioides difficile isolate and interferes with toxin synthesis.
Gut Pathog, 14 (1): 4. [PMID:34991700]
3. Doundoulakis T, Xiang AX, Lira R, Agrios KA, Webber SE, Sisson W, Aust RM, Shah AM, Showalter RE, Appleman JR et al.. (2004)
Myxopyronin B analogs as inhibitors of RNA polymerase, synthesis and biological evaluation.
Bioorg Med Chem Lett, 14 (22): 5667-72. [PMID:15482944]
4. Hu T, Schaus JV, Lam K, Palfreyman MG, Wuonola M, Gustafson G, Panek JS. (1998)
Total Synthesis and Preliminary Antibacterial Evaluation of the RNA Polymerase Inhibitors ±-Myxopyronin A and B.
J. Org. Chem., 63 (7): 2401-2406. DOI: 10.1021/jo9721610
5. Irschik H, Gerth K, Höfle G, Kohl W, Reichenbach H. (1983)
The myxopyronins, new inhibitors of bacterial RNA synthesis from Myxococcus fulvus (Myxobacterales).
J Antibiot (Tokyo), 36 (12): 1651-8. [PMID:6420386]
6. Moy TI, Daniel A, Hardy C, Jackson A, Rehrauer O, Hwang YS, Zou D, Nguyen K, Silverman JA, Li Q et al.. (2011)
Evaluating the activity of the RNA polymerase inhibitor myxopyronin B against Staphylococcus aureus.
FEMS Microbiol Lett, 319 (2): 176-9. [PMID:21477256]
7. Mukhopadhyay J, Das K, Ismail S, Koppstein D, Jang M, Hudson B, Sarafianos S, Tuske S, Patel J, Jansen R et al.. (2008)
The RNA polymerase "switch region" is a target for inhibitors.
Cell, 135 (2): 295-307. [PMID:18957204]